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Changes in the process of cross-linking of collagen
molecules are associated with defects in the bio-
mechanical stability of the extracellular matrix.
Fibrosis of skin is characterized by an increase in
pyridinolines, which are hydroxylysine aldehyde
derived cross-links usually absent in healthy skin. In
this study, we analyzed cross-links in lipodermato-
sclerosis and localized scleroderma to address the
question whether all the mature cross-links currently
characterized are increased in ®brosis in addition to
the increase in pyridinolines. As psoralen plus ultra-
violet A treatment leads to clinical improvement of
®brotic plaques in localized scleroderma we analyzed
the cross-link content in lesional skin after bath psor-
alen plus ultraviolet A therapy. In skin from patients
with localized scleroderma an increase in the total
number of mature cross-links was found to be due
to an increase in both pyridinolines and dehydro-
histidinohydroxymerodesmosine. The concentration
of histidinohydroxylysinonorleucine was unchanged.
By contrast, the total number of mature cross-links
was decreased in lipodermatosclerosis. This decrease
was caused by a decrease of lysine aldehyde derived
cross-links (dehydro-histidinohydroxymerodesmosine
and histidinohydroxylysinonorleucine), whereas the
concentration of pyridinolines increased. A decrease
in the content of pyridinolines after bath psoralen
plus ultraviolet A treatment was found in six out of
nine patients with localized scleroderma, which
might re¯ect a remodeling of the extracellular mat-
rix. Our data provide evidence that sclerosis of skin
is associated with either an increase in the number of
cross-links per molecule of collagen or a change in
the molecular nature of the cross-links formed.
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A
n appropriate stabilization of collagen molecules by
intermolecular collagen cross-links is crucial for the
proper biomechanical function of tissues and organs.
The Ehlers±Danlos syndrome type VI, which is due
to a mutation in the gene of lysylhydroxylase, is
accompanied by changes in the mode of cross-linking leading to
hyper¯exibility of joints and an increased fragility of blood vessels
(Hyland et al, 1992; AcËil et al, 1995). Collagen cross-links consist of
a group of mature compounds, which are endproducts of a
complex process initiated by the lysyl-oxidase-dependent oxidative
deamination of lysine (lys) or hydroxylysine (hyl) residues in
telopeptides forming reactive aldehydes. Subsequent condensation
results in the formation of difunctional intermediate products and
trifunctional or tetrafunctional cross-links. Structurally, the cross-
links consist of two groups comprising (i) compounds that are
derived from a lys residue in the telopeptides of the collagen
molecule [dehydro-histidinohydroxymerodesmosine (D-HHMD),
histidinohydroxylysinonorleucine (HHL)] and (ii) compounds that
require a hyl residue in the telopeptide [pyridinolines: hydro-
xylysylpyridinoline (HP), lysylpyridinoline (LP); pyrrole]. As the lys
residue in the telopeptide of collagen in skin is probably not
hydroxylated, HHL and D-HHMD are generally found, whereas
pyridinolines (HP and LP) occur only in traces (Barnes et al, 1971;
Yamauchi et al, 1987). In contrast, the lys residues in the
telopeptides of skeletal tissue are hydroxylated, resulting in the
generation of HP, LP, and pyrrole as mature cross-links (Eyre et al,
1984; Knott and Bailey, 1998). Recent data showed that sclerosis of
skin [lipodermatosclerosis (LDS), keloid] or organ ®brosis (lung,
liver) is accompanied by an increase in the hyl-derived cross-links
HP and LP. This is due to an increased hydroxylation of the
collagen molecule in both the helical part and the telopeptide,
which in turn determines the type of cross-links (Reiser et al, 1992;
Ricard-Blum et al, 1993; Brinckmann et al, 1996; Uzawa et al,
1998). Furthermore, an increase in HHL content was recently
reported for sclerotic skin of systemic sclerosis and for skin after
radiotherapy (Ishikawa et al, 1998; Sassi et al, in press). It is open to
debate, however, whether the increase in hydroxylysine aldehyde
(hyl-ald) derived cross-links is due to an isolated overhydroxylation
of lys residues or to an increase in the total number of all mature
cross-links caused by a stimulated expression of lysyl oxidase. In this
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study, we compared the pattern of mature collagen cross-links (HP,
LP, HHL, D-HHMD) in localized scleroderma and in LDS. As 8-
methoxypsoralen (8-MOP) plus ultraviolet A (PUVA) therapy is an
effective treatment modality for localized scleroderma (Yamauchi et
al, 1991; Kerscher et al, 1994; Scharffetter-Kochanek et al, 1995;
Stege et al, 1997), we set out to analyze the in¯uence of bath-
PUVA treatment on the concentration of cross-links in vitro and in
localized scleroderma in vivo.
MATERIALS AND METHODS
Human skin samples Skin samples were obtained from patients with
LDS undergoing reconstructive surgery of sclerotic areas and from
patients with localized scleroderma before and directly after the last bath-
PUVA treatment of a total of 36 treatments (LDS, n = 8; localized
scleroderma, n = 9). Age- and site-matched controls were obtained from
normal skin of patients undergoing plastic surgery (n = 9). All biopsies
from patients (LDS and localized scleroderma) and from controls were
performed after the written consent of the donors had been obtained.
Bath-PUVA treatment Nine patients with histologically con®rmed
localized scleroderma were treated with bath-PUVA for 12 wk (total of
36 treatments). During the ®rst 6 wk they were treated four times a
week (24 treatments), and treatments were subsequently reduced to
twice a week. Before UVA exposure the minimal phototoxic dose was
determined. The initial UVA dose was started with 0.2±0.5 J per cm2
corresponding to 30% of the previously determined minimal phototoxic
dose. For irradiation we used a stand-up cubicle emitting UVA isodoses
at every given anatomic side (Medisun, Schulze & Boehm, Cologne,
Germany). The concentration of 8-MOP was 0.5 mg per liter, the water
temperature was 37°C, and the patients bathed for 20 min. Ultra-
sonography (20 DUB, 20 MHz tpm; LuÈneburg, Germany) of lesional
and nonlesional skin at baseline and after treatment was performed. No
serious side-effects such as erythema, pruritus, or severe burning was
observed by any patients.
Pyridinoline analysis (HP, LP) Skin samples were acid hydrolyzed
(6 N HCl, 110°C, 24 h). Fluorescent collagen cross-links HP and LP
were measured in acid hydrolysates by high performance liquid
chromatography after puri®cation by adsorption chromatography (®brous
cellulose powder column, CF-1; Whatman, Spring®eld Mill, Maidstone,
U.K.) (Brinckmann et al, 1996). Chromatography was carried out on an
Inertsil 5 mm column from VDS Optilab using a ¯uorescence detector
RF 1002 from Gynkothek (Gynkothek, Germering, Munich, Germany).
Samples were eluted with a gradient from 5% to 65% acetonitrile in
0.1% hepta¯uorobutyric acid over 25 min at room temperature.
Quantitation of HP and LP was based on calibration with suitable
standards prepared from gelatine. Collagen quantity was calculated from
the content of hydroxyproline (hyp) in acid hydrolysates assuming a
content of 14 mg hyp in 100 mg collagen. Hyp was measured in a color
assay. After acid hydrolysis, dried aliquots were oxidized with chloramine
T and reacted with dimethylaminobenzaldehyde. The color value was
measured at 550 nm and normalized to hyp standard solutions (Bergman
and Loxley, 1963).
Content of lysyl-oxidase-dependent collagen cross-links (HHL, D-
HHMD) Acid hydrolysates of borohydride-reduced and nonreduced
samples were initially separated on CF-1 cellulose columns to remove
the bulk of non-cross-linked amino acids. Dried eluates were redissolved
in Na-S buffer and analyzed on the amino acid analyzer (Beckmann,
Germany) using a two buffer gradient system and post column ninhydrin
derivatization. The column was eluted for 20 min with Na-F buffer and
for 40 min with Na-E buffer at 90°C (Beckmann, Germany). Retention
times of individual cross-links were established with authentic cross-link
compounds. Quanti®cation was based on ninhydrin-generated leucine
equivalence factors using 1.97 for HHL. In analogy to the factors
published for HP and desmosine the factor for D-HHMD was arbitrarily
assumed to be 3.4 (Sims et al, 2000).
Amino acid analysis The degree of lysyl hydroxylation was analyzed
in hydrolyzed full-thickness biopsies. Lyophilized samples were
redissolved in sample buffer for amino acid analysis (Na-S) and separated
with an amino acid analyzer using a step gradient of 7.3 ml buffer Na-F
and 3.2 ml Na-D (Beckmann, Germany). The degree of lysyl
hydroxylation was expressed as the ratio of hyl to hyp.
In vitro UVA irradiation HP-containing collagen was isolated by
repeated pepsin digestion (0.1 mg pepsin per mg dry weight of skin, for
24 h at 4°C; ®ve times) of skin with LDS and salt precipitated (4.0 M
NaCl). Skin of LDS was pulverized under liquid nitrogen in a hammer
mill. Aliquots of redissolved collagens (0.2 M NaCl, pH 7.4) or of
pulverized skin were irradiated in the presence and absence of 8-MOP
(80 ng per ml) with different doses of UVA (UVASUN 3000, Mutzhaas,
Munich, Germany). The irradiation was performed once (9 J per cm2) or
repetitively (3 3 9 J per cm2). After irradiation of the PUVA sample,
8-MOP was removed from the collagen solution by dialysis and from
the skin by washing. Subsequently, an aliquot of a freshly prepared
8-MOP solution was added prior to the next irradiation. All experiments
were performed in triplicate.
Radioimmunoassays Carboxyterminal telopeptide of collagen I was
measured in 100 ml aliquots of serum in duplicate using equilibrium
radioimmunoassays for the human antigen (Orion Diagnostica,
Oulunsalo, Finland). Brie¯y, after incubation of samples with the
radiolabeled antigen and rabbit antiserum for 24 h at 37°C, the second
antibody was added for 30 min at 4°C. The precipitate was collected by
centrifugation and counted in a 1272 Clinigamma counter (Wallac,
Turku, Finland), which calculates the standard curve and automatically
gives the result on the basis of this. The intraassay and interassay
coef®cients of variation were about 5% for both assays at the
concentration found in this study.
Electrophoretic separation Aliquots of solubilized collagens were
lyophilized and redissolved in sodium dodecyl sulfate (SDS) sample
buffer in a concentration of 1 mg per ml. Each sample was heated to
95°C for 2 min and quenched on ice prior to sample loading. Separation
of collagen chains on polyacrylamide gels was carried out in the presence
or absence of 2-mercaptoethanol in sample buffer and also under
conditions with delayed reduction. Gels were stained with Coomassie
blue and relative amounts of the different collagen chains were measured
by densitometric scanning using a video scanner for whole band analysis
calibrated by a photographic step tablet (Computer & Vision, LuÈbeck,
Germany; Kodak, Rochester, NY).
Circular dichroism and transition pro®les Circular dichroism
spectra were recorded in a Jasco J-715 A spectropolarimeter, equipped
with a temperature-controlled quartz cuvette of 1 cm path length. The
molar ellipticity was calculated on the basis of a mean residue molar mass
of 96 g per mol. The degree of 100% conversion corresponds to the
ellipticity at 45°C, characteristic for totally denatured collagen. Thermal
transition curves were recorded at a ®xed wavelength (221 nm) by
raising the temperature linearly at a rate of 30°C per h, using a Gilford
temperature programmer.
Statistical analysis Statistical analysis was based on the U test,
according to Wilcoxon, Mann±Whitney, and on the Wilcoxon matched
pairs signed rank test.
RESULTS
Hyl-ald derived cross-links and the degree of lysyl
hydroxylation increase in lesional skin of localized
scleroderma An increase in the content of pyridinolines
occurred in lesional skin of localized scleroderma compared with
healthy controls (localized scleroderma, HP 31 6 18, LP 2.2 6
1.1 mmol per mol; control, HP 5 6 3.2, LP 0.4 6 0.8 mmol per
mol; p < 0.005). In LDS, both pyridinolines showed an increase,
which was not as pronounced as reported earlier (Brinckmann et al,
1996). There is a distinctive difference between the two pathologic
conditions, however: in LDS, the increase of hyl-ald derived cross-
links was mainly due to a proportionally higher formation of HP,
whereas the formation of the two pyridinolines was found to be
stimulated to a similar extent in localized scleroderma (Fig 1a, b).
The increase in pyridinolines in localized scleroderma was
accompanied by a slight but signi®cant elevation of the degree of
lysyl hydroxylation in total skin hydrolysates expressed as hyl/hyp
(localized scleroderma, 0.061 6 0.006; control, 0.048 6 0.010; p
< 0.01). The increase in pyridinolines in the skin of localized
scleroderma was not accompanied by an increase in the serum
concentration of the carboxyterminal telopeptide of collagen I (data
not shown).
Lys-ald derived cross-links increase in localized scleroderma
and decrease in LDS In order to address the question whether
the increase in the concentration of pyridinolines is paralleled by a
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general increase in all mature cross-links, we analyzed the
concentration of mature lys-ald derived compounds in localized
scleroderma and LDS. Interestingly, an increase in the
concentration of D-HHMD was observed in skin of localized
scleroderma, whereas this concentration was decreased in LDS
(Fig 2a). The concentration of HHL was virtually unchanged in
localized scleroderma, whereas in LDS a marked decrease in HHL
was observed (Fig 2b). The concentration of both D-HHMD and
HHL in the skin of localized scleroderma was highly variable. This
variation may re¯ect differences in disease stage, age, and site of
biopsy. It should also be noted that the concentration of cross-links
in the two control pools used as reference for either localized
scleroderma or LDS varied to some extent, which similarly may be
attributed to differences in age and site of biopsy. Taken together,
total mature cross-links (lys-ald and hyl-ald derived cross-links)
increase from 0.67 6 0.46 mol per mol in controls to
1.13 6 0.53 mol per mol in localized scleroderma (p < 0.05),
whereas a decrease was observed in LDS (control, 0.75 6 0.23 mol
per mol; LDS, 0.33 6 0.16 mol per mol; p < 0.005).
In vitro UVA and PUVA treatment degraded HP in intact
collagen molecules In order to study photodegradation of
pyridinolines due to UVA or PUVA treatment, we performed an
in vitro irradiation of pepsin-solubilized collagen with a known
predetermined concentration of pyridinolines and of powdered
skin of LDS. The UVA irradiation of intact collagen molecules
containing HP resulted in a decrease in HP content. Repetitive
irradiation (three times) resulted in enhanced photodegradation of
HP, whereas PUVA treatment of the collagen solution did not
result in a further increase in photodegradation of HP compared to
the UVA treatment. Furthermore, UVA treatment of pulverized
skin resulted in a decrease in HP content. PUVA treatment of the
skin in vitro showed a slight increase in the degradation of HP after
repetitive irradiation compared to the UVA treatment (Table I).
Following UVA and PUVA treatment of collagen solutions no
structural changes and no fragmentation of collagen were observed
by SDS polyacrylamide gel electrophoresis (SDS-PAGE) (Fig 3).
The relative proportions of g-, b- or a-collagen chains and of
collagen III to collagen III and I did not vary (data not shown).
Furthermore, thermal transition curves of irradiated and mock-
irradiated collagen solutions showed no substantial differences in
the melting pro®le of collagen molecules (data not shown).
Bath-PUVA treatment of lesional skin in localized sclero-
derma resulted in a decrease in HP content in six out of nine
patients In six out of nine patients with localized scleroderma, a
decrease in HP content was observed after bath-PUVA, the extent
of which varied between patients from 23% to 73% (p < 0.05). One
patient did not show any change, but in two patients increases in
HP content of 30% and 40% were observed (Fig 4). A decrease in
LP content after bath-PUVA therapy was also observed (p < 0.05).
The degree of lysyl hydroxylation was not altered by bath-PUVA
therapy (hyl/hyp before treatment 0.061 6 0.006, after treatment
Figure 2. The pattern and content of lys-derived cross-links
distinctly differ in skin of localized scleroderma and LDS. (a) D-
HHMD, (b) HHL. Acid hydrolysates of borohydride-reduced and
nonreduced samples were analyzed on the amino acid analyzer using a
two buffer gradient system and post column ninhydrin derivatization.
Each bar corresponds to the mean 6 SD; #p < 0.05, ‘p > 0.05, *p
< 0.005.
Figure 1. Increased content of pyridinolines in skin of localized
scleroderma and LDS. (a) HP, (b) LP. Fluorescent collagen cross-links
HP and LP were measured in acid hydrolysates. Each bar corresponds to
the mean 6 SD, *p < 0.005.
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0.063 6 0.005; p > 0.05). Ultrasonographic measurements of
lesional skin performed at baseline and after treatment showed a
reduction in sonographic thickness (diameter of dermis before
treatment 2.4 6 0.5 mm, after treatment 2.1 6 0.5 mm; p < 0.05).
The HP content in lesional skin before and after treatment did not
correlate with skin thickness. Clinically, the PUVA treatment
resulted in an improvement of sclerosis in all patients.
DISCUSSION
The pattern and formation of lys-ald and hyl-ald derived collagen
cross-links are thought to be determined by physiologic require-
ments and not collagen types and their proportion in tissues. Hyl-
ald derived cross-links are found in mineralized tissues such as bone
and dentine as well as in cartilage, whereas they are virtually absent
in skin and cornea (Reiser et al, 1992; Yamauchi et al, 1996; Bailey
et al, 1998). The initial step in collagen cross-link formation, which
apparently limits the total amount of enzymatic cross-links between
collagen molecules, is the oxidative deamination of certain lys and
hyl residues located in the telopeptide region of collagen molecules.
It has been shown in animal experiments that the decline in the
concentration of collagen cross-links after inhibition of lysyl
oxidase by addition of b-aminoproprionitrile parallels the decrease
in biomechanical strength of the tissue studied (Oxlund et al, 1995;
Bruel et al, 1998). An increase in cross-links of the pyridinoline type
was observed in sclerotic conditions such as nephrosclerosis, lung
®brosis or LDS, and hypertrophic scars (Moriguchi and Fujimoto,
1979; Last et al, 1990; Brinckmann et al, 1996; Di Donato et al,
1997). It is open to debate, however, whether this increase is due to
a general increase in total number of cross-links or to an exclusive
increase in HP. In our study, the total number of analyzed cross-
links per collagen molecule showed an increase in localized
scleroderma. The pattern of cross-links was characterized by an
increase in pyridinolines and D-HHMD, whereas the concentration
of HHL was not altered, an observation that was previously
reported for keloids (Uzawa et al, 1998). The increase in the
concentration of hyl-derived cross-links was not accompanied by
an increase in the serum concentration of carboxyterminal
telopeptide of collagen I. This may be due to the overall small
area of skin involved in our patients (less than 15%) and to the fact
that the absolute levels of pyridinolines in localized scleroderma
were low compared to skeletal tissues (Hunzelmann et al, 1998). In
lesional skin of LDS a decrease in the content of cross-links
analyzed was observed, which was due to a marked decrease in
HHL and D-HHMD. The increase in the concentration of
pyridinolines in LDS was not as marked as reported earlier
probably due to different stages of disease (Brinckmann et al, 1996).
The reason why different cross-link patterns are formed in
localized scleroderma and LDS is not clear, although it is
conceivable that stimulated expression of lysyl oxidase in localized
scleroderma resulted in an overall increase in the concentration of
cross-links per collagen molecule (Chanoki et al, 1995). The higher
increase in hyl-ald derived cross-links (+615%) than in lys-ald
derived cross-links (+164%) argues for an additional stimulation of
the expression of lysyl hydroxylase in localized scleroderma. Our
observation of a slight but signi®cant elevation of the degree of lys
hydroxylation in whole skin samples is in line with this notion.
By contrast, the altered cross-link pattern in LDS seems to be due
to an isolated overhydroxylation of lysyl residues of the collagen
molecules leading to a decrease in lys-ald derived cross-links and a
sole increase in pyridinolines (Brinckmann et al, 1999).
Furthermore, it is conceivable that stimulated expression of both
lysyl oxidase and lysyl hydroxylase in a ®rst step leads to an increase
in lys-ald and hyl-ald derived cross-links. In a second step lys-ald
derived cross-links may be cleaved in preference to pyridinolines by
collagenase, the expression of which has been found to be
enhanced in LDS (Vater et al, 1974; Herouy et al, 1998).
Figure 3. No fragmentation of soluble collagen following UVA
or PUVA treatment. HP-containing collagen was isolated by repeated
pepsin digestion (0.1 mg pepsin per mg dry weight of skin, for 24 h at
4°C; ®ve times) of skin with LDS. After three treatments with 9 J per
cm2 UVA in the presence or absence of 8-MOP collagens were
lyophilized and separated by SDS-PAGE. Electrophoresis was performed
in the absence (±MESH) or presence (+MESH) of mercaptoethanol (A,
standard of pepsin solubilized bovine skin collagen; B, mock-irradiated
control; C, PUVA; D, UVA).
Figure 4. Bath-PUVA treatment of lesional skin in localized
scleroderma resulted in a decrease in HP content in six out of
nine patients. HP content in skin of localized scleroderma after PUVA
therapy is expressed as a percentage of HP content before PUVA
therapy. Each bar represents the HP content of a patient; #p < 0.05.
Table I. UVA and PUVA treatment in vitro degraded HP in intact collagen molecules and pulverized skina
Mock
irradiation
UVA
9 J per cm2
PUVA
9 J per cm2
UVA
3 3 9 J per cm2
PUVA
3 3 9 J per cm2
Collagen solution 0.024 0.009 6 0.0017 0.011 6 0 0.006 6 0.0006 0.006 6 0.0006
Pulverized skin 0.072 0.019 6 0.0040 0.021 6 0.0010 0.020 6 0.0045 0.014 6 0.0006
aMean
6 SD, n = 3.
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Several studies have shown clinical improvement following bath-
PUVA treatment in localized scleroderma, which was explained by
an increase in synthesis and activation of matrix metalloproteinases
with proteolytic speci®city for interstitional collagens (Scharffetter
et al, 1991; Petersen et al, 1992; Herrmann et al, 1998). We found in
six out of nine patients a decrease in the content of pyridinolines
after bath-PUVA, re¯ecting a remodeling of the extracellular
matrix probably induced by an altered cytokine pro®le. We did not
observe a decrease in the sclerosis-speci®c cross-link HP in three
patients with localized scleroderma, which may be due to different
concentrations of dehydro-dihydroxylysinonorleucine DHLNL at
the time of biopsy. In addition to the effect of remodeling of
sclerotic skin it is conceivable that a direct photodegradation may
contribute to the removal of pyridinolines (Sakura et al, 1982;
Meddah et al, 2000). Our in vitro irradiation of solubilized collagen
and pulverized skin clearly showed that HP bound to intact
collagen molecules was effectively degraded by UVA. PUVA
treatment in vitro apparently enhanced the UVA-induced photo-
degradation of HP only when repetitively performed on pulverized
skin. The generation of reactive oxygen species upon UVA
irradiation of 8-MOP and chromophores present in skin may
account for this effect (Scharffetter-Kochanek et al, 2000). The
irradiation of collagen with UVA in the presence or absence of
8-MOP did not lead to any structural changes or to fragmentation
of collagen.
In summary, our study provides ®rst evidence that sclerosis of
skin is accompanied by a change in the quantitative and/or
qualitative formation of collagen cross-links. The role that lys-ald
and hyl-ald derived collagen cross-links have in changing the
physicomechanical properties of skin tissue is open to debate.
This work was supported by a grant from the Deutsche Forschungsgemeinschaft
(SFB 367-A7), the Deutsche Gesellschaft fuÈr Phlebologie, and the
Bundesministerium fuÈr Bildung und Forschung (BMBF 07U5B55B/1). We
thank Mrs Fischer and Mrs Alexander for their excellent technical assistance.
REFERENCES
AcËil Y, Vetter U, Brenner R, MuÈller PK, Brinckmann J: Diagnosis of Ehlers±Danlos
syndrome type VI. Cross-link pattern in tissue and urine sample as a diagnostic
marker. J Am Acad Dermatol 33:522±524, 1995
Bailey AJ, Paul RG, Knott L: Mechanisms of maturation and ageing of collagen. Mech
Ageing Dev 106:1±56, 1998
Barnes MJ, Constable BJ, Morton LF, Kodicek E: Hydroxylysine in the N-terminal
regions of the 1¢- and 2¢-chains of various collagens. Biochem J 125:433±437,
1971
Bergman I, Loxley R: Two improved and simpli®ed methods for the
spectrophotometric determination of hydroxyproline. Anal Chem 35:1961±
1965, 1963
Brinckmann J, AcËil Y, Tronnier M, et al: Altered x-ray diffraction pattern is
accompanied by a change in the mode of cross-link formation in
lipodermatosclerosis. J Invest Dermatol 107:589±592, 1996
Brinckmann J, Notbohm H, Fietzek P, Tronnier M, Schmeller W, BaÈtge B, MuÈller
PK: Over-hydroxylation of lysyl residues is the initial step for altered collagen
cross-links and ®bril architecture in ®brotic skin. J Invest Dermatol 113:617±621,
1999
Bruel A, Ortoft G, Oxlund H: Inhibition of cross-links in collagen is associated with
reduced stiffness of the aorta in young rats. Atherosclerosis 140:135±145, 1998
Chanoki M, Ishii M, Kobayashi H, Fushida H, Yashiro N, Hamada T, Ooshima A:
Increased expression of lysyl oxidase in skin with scleroderma. Br J Dermatol
133:710±715, 1995
Di Donato A, Ghiggeri GM, Di Duca M, Jivotenko E, Acinni R, Campolo J,
Ginervi F, Gusmano R: Lysyl oxidase expression and collagen cross-linking
during chronic adriamycin nephropathy. Nephron 76:192±200, 1997
Eyre DR, Paz MA, Gallop PM: Cross-linking in collagen and elastin. Annu Rev
Biochem 537:717±748, 1984
Herouy Y, May AE, Pornschlegel G, et al: Lipodermatosclerosis is characterized by
elevated expression and activation of matrix metalloproteinases: implications
for venous ulcer formation. J Invest Dermatol 111:822±827, 1998
Herrmann G, Brenneisen P, Wlaschek M, et al: Psoralen photoactivation promotes
morphological and functional changes in ®broblast in vitro reminiscent of
cellular senescence. Cell Sci 111:759±767, 1998
Hunzelmann N, Risteli J, Risteli L, Sacher C, Vancheeswaran R, Black C, Krieg T:
Circulating type I collagen degradation products: a new serum marker for
clinical severity in patients with scleroderma? Br J Dermatol 139:1020±1025,
1998
Hyland J, Ala-Kokko L, Royce P, Steinmann B, Kivirikko K, MyllylaÈ R: A
homozygous stop codon in the lysyl hydroxylase gene in two siblings with
Ehlers±Danlos syndrome type VI. Nature Genet 2:228±231, 1992
Ishikawa O, Kondo A, Miyachi Y: Mature type of skin collagen cross-link,
histidinohydroxylysinonorleucine, is signi®cantly increased in the skin of
systemic sclerosis. Arthritis Rheum 41:376±377, 1998
Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Roecken M:
Treatment of localized scleroderma with PUVA bath chemotherapy. Lancet
343:1233, 1994
Knott L, Bailey AJ: Collagen cross-links in mineralizing tissues: a review of their
chemistry, function and clinical relevance. Bone 22:181±187, 1998
Last JA, King TE Jr, Nerlich AG, Reiser KM: Collagen cross-linking in adult patients
with acute and chronic ®brotic lung disease. Am Rev Respir Dis 141:307±313,
1990
Meddah B, Kamel S, Giroud C, Brazier M: Effects of ultraviolet light on free and
peptide-bound pyridinoline and deoxypyridinoline cross-links. Protective
effect of acid pH against photolytic degradation. J Photochem Photobiol B Biol
54:168±174, 2000
Moriguchi T, Fujimoto D: Crosslink of collagen in hypertrophic scar. J Invest
Dermatol 72:43±145, 1979
Oxlund H, Barckman M, Ortoft G, Andreassen TT: Reduced concentrations of
collagen cross-links are associated with reduced strength of bone. Bone
17:365S±371S, 1995
Petersen MJ, Hansen C, Craig S: Ultraviolet A irradiation stimulates collagenase
production in cultured human ®broblasts. J Invest Dermatol 99:440±444, 1992
Reiser K, McCormick RJ, Rucker RB: Enzymatic and nonenzymatic cross-linking
of collagen and elastin. FASEB J 6:2439±2449, 1992
Ricard-Blum S, Esterre P, Grimaud JA: Collagen cross-linking by pyridinoline
occurs in non-reversible skin ®brosis. Cell Mol Biol 39:723±727, 1993
Sakura S, Fujimoto D, Sakamoto K, Mizuno A, Motegi K: Photolysis of pyridinoline,
a cross-linking amino acid of collagen, by ultraviolet light. Can J Biochem
60:525±529, 1982
Sassi ML, Jukkola A, Riekki R, HoÈyhtyaÈ M, Risteli L, Oikarinen A, Risteli J: Type I
collagen turnover and cross-linking are increased in irradiated skin of breast
cancer patients. Radiother Oncol, in press
Scharffetter K, Wlaschek M, Hogg A, et al: UVA irradiation induces collagenase in
human dermal ®broblasts in vitro and in vivo. Arch Dermatol Res 283:506±511,
1991
Scharffetter-Kochanek K, Goldermann R, Lehmann P, Holzle E, Goerz G: PUVA
therapy in disabling pansclerotic morphoea of children [letter]. Br J Dermatol
132:830±831, 1995
Scharffetter-Kochanek K, Brenneisen P, Wenk J, et al: Photoaging of the skin from
phenotype to mechanisms. Exp Gerontol 35:307±316, 2000
Sims TJ, Avery NC, Bailey AJ: Quantitative determination of collagen crosslinks.
Meth Mol Biol 139:11±26, 2000
Stege H, Berneburg M, Humke S, et al: High-dose UVA1 radiation therapy for
localized scleroderma. J Am Acad Dermatol 36:938±944, 1997
Uzawa K, Marshall MK, Katz EP, Tanzawa H, Yeowell HN, Yamauchi M: Altered
posttranslational modi®cations of collagen in keloid. Biochem Biophys Res Com
249:652±655, 1998
Vater CA, Harris ED Jr, Siegel RC: Native cross-links in collagen ®brils induce
resistance to human synovial collagenase. Biochem J 181:639±645, 1979
Yamauchi M, London RE, Guenat C, Hashimoto F, Mechanic GL: Structure and
formation of a stable histidine-based trifunctional cross-link in skin collagen.
J Biol Chem 262:11428±11434, 1987
Yamauchi M, Prisayanh P, Haque Z, Woodley DT: Collagen cross-linking in sun-
exposed and unexposed sites of aged human skin. J Invest Deramtol 97:938±941,
1991
Yamauchi M, Chandler GS, Tanzawa H, Katz EP: Cross-linking and the molecular
packing of corneal collagen. Biochem Biophys Res Com 219:311±315, 1996
VOL. 117, NO. 2 AUGUST 2001 COLLAGEN ANALYSIS IN SCLEROTIC SKIN 273
